Sberbank of Russia:企業のM&A・事業提携・投資動向

◆英語タイトル:Sberbank of Russia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1353
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:146
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:キプロス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sberbank of Russia – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Sberbank of Russia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sberbank of Russia since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Sberbank of Russia’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Sberbank of Russia. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Sberbank of Russia’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Sberbank of Russia and its subsidiaries since 2007.
- Information about key financial and legal advisors for Sberbank of Russia’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Sberbank of Russia’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 92
Corporate Venturing – Overview 92
Corporate Venturing – Deal reports 93
PARTNERSHIP 96
Partnership – Overview 96
Partnership – Deal reports 97
CAPITAL RAISING 104
Capital Raising – Deal reports 104
DIVESTMENTS 113
Divestments – Overview 113
Divestments – Deal reports 114
PRIVATE EQUITY & OWNERSHIP 134
Private Equity and Ownership – Deal reports 134
APPENDIX 136
Contact Us 136
About MarketLine Financial Deals Database 136
Deal Definition and Methodology 138
About MarketLine 145

List of Tables
Table 1: Sberbank of Russia M&A volume and value trend (2014-YTD2018)
Table 2: Sberbank of Russia M&A activity by geography (2014-YTD2018)
Table 3: Sberbank of Russia corporate venturing volume and value trend (2014-YTD2018)
Table 4: Sberbank of Russia corporate venturing by geography (2014-YTD2018)
Table 5: Sberbank of Russia partnership volume and value trend (2014-YTD2018)
Table 6: Sberbank of Russia partnership trend by key deal type (2014-YTD2018)
Table 7: Sberbank of Russia divestments volume and value trend (2014-YTD2018)
Table 8: Sberbank of Russia divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Sberbank of Russia M&A volume and value trend (2014-YTD2018)
Figure 2: Sberbank of Russia M&A activity by geography (2014-YTD2018)
Figure 3: Sberbank of Russia corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Sberbank of Russia corporate venturing by geography (2014-YTD2018)
Figure 5: Sberbank of Russia partnership volume and value trend (2014-YTD2018)
Figure 6: Sberbank of Russia partnership trend by key deal type (2014-YTD2018)
Figure 7: Sberbank of Russia divestments volume and value trend (2014-YTD2018)
Figure 8: Sberbank of Russia divestments by geography (2014-YTD2018)

★海外企業調査レポート[Sberbank of Russia:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PanAust Ltd:企業の戦略・SWOT・財務情報
    PanAust Ltd - Strategy, SWOT and Corporate Finance Report Summary PanAust Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Trinity Industries Inc (TRN):企業の財務・戦略的SWOT分析
    Trinity Industries Inc (TRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Techpool Bio-Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Techpool Bio-Pharma Co Ltd (Techpool Bio-Pharma) is a biopharmaceutical company. The company manufactures urinary protein biopharmaceuticals in critical care conditions. The company’s products include ulinastatin for injection, urinary kallidinogenase for injection, urokinase for injection a …
  • IndusInd Bank Ltd:企業のM&A・事業提携・投資動向
    IndusInd Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IndusInd Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Jack Chia Industries (Thailand) Public Company Ltd (JCT):企業の財務・戦略的SWOT分析
    Jack Chia Industries (Thailand) Public Company Ltd (JCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Aon Plc:企業の戦略・SWOT・財務分析
    Aon Plc - Strategy, SWOT and Corporate Finance Report Summary Aon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • ContextVision AB (COV):企業の財務・戦略的SWOT分析
    Summary ContextVision AB (ContextVision) is a medical technology company that specializes in image analysis and artificial intelligence software solutions. The company develops image enhancement software solutions for magnetic resonance imaging, digital pathology, ultrasound, X-ray, fluoroscopy, mam …
  • ZIOPHARM Oncology Inc (ZIOP):製薬・医療:M&Aディール及び事業提携情報
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc, is a next-generation immune therapies provider. The company offers controlled IL-12 and t-cell therapy. Its next-generation immune therapie platform provides turning cold tumors hot by activating an immune response and non viral genetic …
  • CPR Pharma Services Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary CPR Pharma Services Pty Ltd (CPR) is a contract research organization that offers drug development and clinical trial services. The organization's services include clinical project management and monitoring, data management, statistical and pharmacokinetic services, and bioanalytical service …
  • NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company provides DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DN …
  • Energias de Portugal SA (EDP)-エネルギー分野:企業M&A・提携分析
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation assets including wind, sola …
  • Orlen Upstream Sp zoo:石油・ガス:M&Aディール及び事業提携情報
    Summary Orlen Upstream Sp zoo (Orlen Upstream), a subsidiary of Polski Koncern Naftowy Orlen SA is an oil and gas company that offers petroleum products and natural gas. The company provides products such as motor fuel, diesel, LPG, marine fuel, aviation fuel, greases, kerosene, brake fluids, techni …
  • Sandvik AB (SAND):企業の財務・戦略的SWOT分析
    Sandvik AB (SAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析
    Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial …
  • Deutsche Ruckversicherung AG:企業の戦略・SWOT・財務情報
    Deutsche Ruckversicherung AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Ruckversicherung AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • LI-COR Inc-製薬・医療分野:企業M&A・提携分析
    Summary LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnolo …
  • Wolverine World Wide, Inc.:企業の戦略・SWOT・財務情報
    Wolverine World Wide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wolverine World Wide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Commercial Bank Of Kuwait Sak
    Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆